Friday, August 21, 2026

Your Weekly Event Guide: Expand Your Learnings and Discover Exciting Opportunities

Discover the top events for you in our Weekly Event Guide


NDS Submissions Explained: Where Applications Break Down

Sep 10 | 2:00 PM - 4:00 PM (EST) (Online)

Proof, Not Promise: How AI is Actually Changing Pharma

Sep 17 | 2:00 PM - 4:00 PM (EST) (Online)

GMP in Practice:

What Inspections Expect for 2026

Sep 24 | 2:00 PM - 4:00 PM (EST) (Online)


Are you ready to expand your learnings?


Broaden your knowledge and delve into new horizons with AAPS!


LinkedIn  YouTube  Facebook  Instagram  Web

Meet Your Instructor: Raymond Ho

Date & Time

Sep 10, 2026

2:00 PM - 4:00 PM (EST)


How is the Workshop delivered?

Live. Virtual. Interactive. Instructor-led.

NDS Submissions Explained: Where Applications Break Down

Greetings!


Meet the instructor behind NDS Submissions Explained.


Raymond Ho is a Regulatory Affairs professional with over seven years of experience across pharmaceuticals, medical devices, and natural health products, bringing a practical, cross-sector perspective to the regulatory submission process.


Throughout his career, Raymond has led drug submissions through Health Canada and the FDA, including new and supplemental drug submissions, Drug Master Files, and eCTD filings. His experience also includes regulatory strategy, product lifecycle management, pharmacovigilance, labeling compliance, and post-market requirements.


At Johnson & Johnson MedTech, Raymond has led regulatory strategy and Health Canada submissions for a sophisticated portfolio of high-risk orthopedic medical devices. Across his career, he has also built and mentored regulatory teams, giving him a strong understanding of both the technical requirements and the practical realities of working in Regulatory Affairs.


In NDS Submissions Explained, Raymond will draw on this hands-on experience to introduce participants to the drug development and approval pathway, New Drug Submissions, pre-submission meetings, CTD structure, eCTD filings, and other foundational elements of the Canadian regulatory process.



*All participants will receive a Certificate of Attendance upon completion.

Interested in this workshop?

Register today by calling our team at 416-628-7575 or email us at events@aapspharma.com

LinkedIn  Web

Thursday, August 20, 2026

AI in Pharma: What’s Proven, What Isn’t?

Date & Time

Sep 17, 2026

2:00 PM - 4:00 PM (EST)


How is the Workshop delivered?

Live. Virtual. Interactive. Instructor-led.

Proof, Not Promise: How AI is Actually Changing Pharma

AI Is Moving Fast. Evidence Matters More.

The conversation around AI in pharma has changed.


The question is no longer simply what AI could do. As its use expands across drug discovery, clinical trials, and safety, the more important questions are what has actually been proven, where the limitations remain, and how regulatory expectations are evolving alongside the technology.


That distinction matters.


An AI application showing promise in drug discovery is not the same as one being relied upon in a regulated clinical environment. And as applications move closer to decisions affecting development, evidence, compliance, and patient safety, understanding context of use, risk, and regulatory status becomes increasingly important.


Proof, Not Promise: How AI Is Actually Changing Pharma takes a deeper, evidence-based look at this changing landscape, including:


  • Discovery: Where AI is producing tangible results and where expectations still exceed the evidence
  • Clinical Trials: How AI and Big Data are changing the way trials can be designed, conducted, and evaluated
  • Safety: Where AI is influencing the analysis and management of increasingly complex information
  • Regulation: How FDA, EMA, and ICH frameworks are responding, including what is currently binding versus still evolving
  • What Comes Next: The developments most likely to affect regulatory and compliance obligations over the next 12 to 18 months
    

Rather than treating AI as one technology with one level of maturity, this workshop provides a framework for asking a more useful question:


What is the evidence, and is it sufficient for this particular use?

For professionals already familiar with the basics of AI, the session is designed to help connect the technology to the real operating, regulatory, and compliance environment of pharma today.

Interested in this workshop?

Register today by calling our team at 416-628-7575 or email us at events@aapspharma.com

LinkedIn  Web